ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 119 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $102 | -84.8% | 15,264 | -80.8% | 0.01% | -86.6% |
Q2 2023 | $669 | -27.5% | 79,707 | -14.2% | 0.07% | -26.4% |
Q1 2023 | $923 | -7.4% | 92,944 | -35.1% | 0.09% | -26.6% |
Q4 2022 | $997 | -99.8% | 143,208 | +37.9% | 0.12% | +67.6% |
Q3 2022 | $555,000 | +108.6% | 103,848 | +73.3% | 0.07% | +105.6% |
Q1 2022 | $266,000 | -47.2% | 59,934 | -52.5% | 0.04% | -42.9% |
Q4 2021 | $504,000 | -44.4% | 126,114 | +22.1% | 0.06% | -31.5% |
Q3 2021 | $907,000 | +250.2% | 103,276 | +351.6% | 0.09% | +217.2% |
Q2 2021 | $259,000 | -38.3% | 22,869 | -62.6% | 0.03% | -58.0% |
Q4 2020 | $420,000 | +122.2% | 61,220 | +140.1% | 0.07% | +115.6% |
Q3 2020 | $189,000 | – | 25,503 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 3,031,915 | $20,253,192 | 21.02% |
Perceptive Advisors | 11,350,085 | $75,818,568 | 2.53% |
JOHNSON & JOHNSON | 394,834 | $2,637,491 | 0.97% |
Joseph P. Lucia & Associates, LLC | 28,331 | $189,251 | 0.13% |
WOODSTOCK CORP | 137,179 | $916,356 | 0.12% |
Palo Alto Investors LP | 160,800 | $1,074,144 | 0.10% |
Affinity Asset Advisors, LLC | 44,348 | $296,245 | 0.08% |
Verition Fund Management LLC | 935,273 | $6,247,624 | 0.07% |
FOX RUN MANAGEMENT, L.L.C. | 33,519 | $223,907 | 0.07% |
TOBIAS FINANCIAL ADVISORS, INC. | 34,173 | $228,276 | 0.06% |